Mao C, Zhu J J, Hu Y F, Ma Q Q, Qiu Y Z, Zhu A P, Zhao W B, Shen J
College of Chemistry and Environment Science, Nanjing Normal University, Nanjing 210097, China.
Colloids Surf B Biointerfaces. 2004 Oct 10;38(1-2):47-53. doi: 10.1016/j.colsurfb.2004.08.007.
Immobilization of the anticoagulative or antithrombogenic biomolecule has been considered as one of the important methods to improve the blood compatibility of artificial biomaterials. In this study, a novel immobilization reaction scheme was utilized to incorporate O-butyrylchitosan (OBCS) onto the activated glass surface with an aim to develop an anticoagulative substrate. Activation of the glass surface was carried out by silanization and then OBCS was grafted to the silanized surface via a radiation grafting technique. The OBCS-grafted glass surfaces were characterized by electron spectroscopy for chemical analysis (ESCA) and atomic force microscopy (AFM). The blood compatibility of the OBCS-grafted glass was evaluated by platelet rich plasma (PRP) contacting experiments and protein adsorption experiments in vitro. These results have demonstrated that the surface with immobilized OBCS shows much less platelet adhesive and fibrinogen adsorption compared to the control surface. Therefore, the novel reaction scheme proposed here is very promising for future development of an anticoagulative glass substrate.
固定抗凝或抗血栓形成生物分子被认为是改善人工生物材料血液相容性的重要方法之一。在本研究中,采用了一种新型的固定反应方案,将O-丁酰壳聚糖(OBCS)结合到活化玻璃表面,旨在开发一种抗凝底物。通过硅烷化对玻璃表面进行活化,然后通过辐射接枝技术将OBCS接枝到硅烷化表面。通过化学分析电子能谱(ESCA)和原子力显微镜(AFM)对接枝了OBCS的玻璃表面进行表征。通过富含血小板血浆(PRP)接触实验和体外蛋白质吸附实验评估接枝了OBCS的玻璃的血液相容性。这些结果表明,与对照表面相比,固定有OBCS的表面显示出更少的血小板粘附和纤维蛋白原吸附。因此,本文提出的新型反应方案对于抗凝玻璃底物的未来发展非常有前景。